MEDICAL
EXCELLENCE IN CARDIOVASCULAR CARE
DR MD MISBAHUL FERDOUS
Dr Md Misbahul Ferdous is a Bangladeshi citizen with a MBBS degree from Bangladesh and a Master ’ s degree and PhD in Cardiology from the prestigious Shandong University in China . Dr Misbah also underwent extensive training in different fields of cardiology at the world ’ s top hospitals . He got his 3D TEE training from the University of Alabama in the US and at Apollo Hospital in India . He went to Taiwan for Complex PCI training at the Cathay General Hospital and did a Fellowship in interventional cardiology at the Ageo General Hospital in Japan .
Dr Misbahul Ferdous is dedicated to cardiovascular care . For the past several years , he was working for the development of primary PCI treatment facilities in “ Belt and Road ” countries . His hospital is equipped with modern technology and staffed with world famous cardiologists . Maximum support for patients is assured with more than 13 countries cooperating in the field of cardiology .
His dream is to make one APP for primary PCI treatment which can be used in many countries that will connect with doctors , patients , ambulance services , cath lab staff , and young cardiologist training for primary PCI .
He believes in “ ONE BELT ONE ROAD ONE HEART .”
EXCELLENCE IN CARDIOVASCULAR CARE
PROFESSOR WU YONGJIAN
Professor Wu Yongjian ’ s positions include : Faculty of Medicine at Peking Union Medical College , Tshinghua University Fuwai Hospital , National Centre for Cardiovascular Diseases , Associate Director of the Coronary Heart Disease Centre , and Associate Director of the Structural Heart Disease Centre .
Dr Wu has been a leading figure in the field of interventional cardiology for more than 20 years and done an extensive amount of exploratory work on coronary heart disease combined with diabetes and chronic renal insufficiencies . For ten years , his team performed more than 3,000 percutaneous coronary interventions per year . He uses the latest cutting edge innovations in cardiology and is a leader in new treatments , such as transcatheter aortic valve replacement , rotablator operations , and coronary laser atherectomy catheters ( ELCA ).
He was the primary investigator ( or co-PI ) on over 40 clinical trials and has published over 120 peer-reviewed articles . Notably , he led China ’ s DVD study that characterized valvular heart disease patients in China . Internationally , Dr Wu is a fellow at
54 2020 AWARDS SPECIAL GlobalHealthAsiaPacific . com